ASCENDIS PHARMA A/S
ASND·04351P101·US·ADR·Healthcare - Biotechnology-13D/G
ASND (ASCENDIS PHARMA A/S) is held by 3 institutional investors as of Q2 2026. Largest holders: Neuberger Berman Group LLC ($38.1M), Quadrature Capital Ltd ($10.9M), HUNTINGTON NATIONAL BANK ($244). Net institutional sentiment: Bearish.
3
Holders
$49M
Total Value
2% (120)
Consensus
2 buying - 118 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 15, 2026 · Insiders Sep 9, 2026 · Activists May 15, 2026 · Congress none
InsiderBMBodenhoff MadsSell $811KSep 8, 2026
InsiderBMBodenhoff MadsExercise 3K shSep 8, 2026
InsiderHLHOLTUG LARSSell $62KSep 2, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 121
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer